University of Health Sciences and Pharmacy, Pharmaceutical Sciences, and Administration in St. Louis carries a specialized cost structure that reflects its health-sciences focus.
Select your family income to see your estimated cost
Net prices are averages and may vary. Based on federal data for first-time, full-time students receiving aid.
| Cost Category | Amount |
|---|---|
| Total Cost of Attendance (Sticker Price) | $54,802 |
| Tuition and Fees | $32,550 |
| Room and Board | $15,450 |
| Books and Supplies | $1,200 |
| Average Financial Aid (Grants and Scholarships) | -$22,985 |
| Average Net Price (What Families Pay) | $31,817 |
| Family Income | Net Price |
|---|---|
| $0–30k | $24,456 |
| $30–48k | $28,969 |
| $48–75k | $22,688 |
| $75–110k | $34,490 |
| $110k+ | $34,668 |
University of Health Sciences and Pharmacy, Pharmaceutical Sciences, and Administration in St. Louis carries a specialized cost structure that reflects its health-sciences focus. Low-income families pay approximately $24,456 per year in net price, middle-income families see annual costs around $22,688, and higher-income families pay approximately $34,668. Azimuth ranks University of Health Sciences and Pharmacy, Pharmaceutical Sciences, and Administration In St. Louis #1106 for post-graduation affordability among nonprofit four-year institutions — in the 22.4 percentile for post-graduation affordability among nonprofit four-year institutions. As with most specialized health-sciences institutions, the gap between published cost and net price depends heavily on the aid package a student qualifies for, and families should treat the income-band figures as medians within each band rather than guaranteed outcomes. Need-based aid plays a meaningful role in shaping what families actually pay. The institution participates in federal, state, and institutional aid programs, and students applying through the FAFSA may qualify for grants and subsidized loans that reduce out-of-pocket costs. Because University of Health Sciences and Pharmacy, Pharmaceutical Sciences, and Administration In St. Louis concentrates its programs in pharmacy, health sciences, and related professional fields, the student population skews toward upper-division and professional-degree tracks where aid structures can differ from traditional four-year undergraduate patterns. Families weighing the — the gap between sticker price and what households actually pay — should request a net-price estimate directly from the institution's financial aid office. Median federal student loan debt at graduation is $17,755, and families using Parent PLUS borrow a median of $41,572; private or institutional loans may add further borrowing that falls outside these federal-only figures — see the for how household context shapes PLUS decisions. For a graduate at the institution's median four-year earnings of $131,813, median federal debt of $17,755 projects to a monthly payment of about $201 under standard ten-year repayment. For personalized projections across earnings scenarios — including Parent PLUS planning — use .
How much students borrow and whether debt is manageable given outcomes.
Debt is well below typical first-year earnings — generally considered very manageable.
How cost compares to graduate earnings and value added.
Graduates of University of Health Sciences and Pharmacy, Pharmaceutical Sciences, and Administration In St. Louis earn median earnings of $131,813 four years after enrollment, placing University of Health Sciences and Pharmacy, Pharmaceutical Sciences, and Administration In St. Louis in the 99.9 percentile for median earnings four years after enrollment among nonprofit four-year institutions. That figure runs above the $57,042 median at comparable institutions (same control and size band). Graduates earn about $77,135 more than similar students at comparable institutions, placing University of Health Sciences and Pharmacy, Pharmaceutical Sciences, and Administration In St. Louis in the 100th percentile for earnings beyond expectations among nonprofit four-year institutions. Azimuth ranks University of Health Sciences and Pharmacy, Pharmaceutical Sciences, and Administration In St. Louis #29 for return on investment among nonprofit four-year institutions. As a specialized health sciences institution in MO, the university channels graduates into clinical and pharmaceutical career paths where early-career compensation tends to be strong relative to MO's no-degree-equivalent earnings baseline of $31,959. The earnings pattern reflects University of Health Sciences and Pharmacy, Pharmaceutical Sciences, and Administration In St. Louis's concentrated focus on Health. Pharmacy, Pharmaceutical Sciences, and Administration, Pharmacy, Pharmaceutical Sciences, and Administration, Pharmaceutical Sciences, and Administration, and Administration combines the largest cohort with strong earnings, making it the primary driver of the institution's overall return profile. Pharmacy, Pharmaceutical Sciences, and Administration, Pharmacy, Pharmaceutical Sciences, and Administration, Pharmaceutical Sciences, and the Administration, and Administration program graduates 74 students annually and anchors the university's degree output. Because the program portfolio is narrow — built almost entirely around health and pharmaceutical sciences — outcomes are more uniform than at broad-curriculum institutions, and the earnings story is largely the story of a single professional field rather than a diversified mix of disciplines.
